C-Path

@CPathInstitute

Critical Path Institute - Accelerating the Path to a Healthier World

Tucson, AZ
Vrijeme pridruživanja: listopad 2012.

Tweetovi

Blokirali ste korisnika/cu @CPathInstitute

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CPathInstitute

  1. 24. sij

    C-Path’s ePRO Consortium is co-sponsoring the 2020 Digital Technology in Clinical Trials Conference, March 30-31 in Boston. Register now for early bird rates:

    Poništi
  2. 22. sij
    Poništi
  3. 18. sij

    C-Path's Regulatory Science met w/the SAWP on the qualification procedure for a Duchenne simulator. Proud to be accelerating development in DMD for patients around the globe.

    Poništi
  4. 23. pro 2019.

    Happy Holidays from your friends at C-Path.

    Poništi
  5. 19. pro 2019.

    C-Path’s ePRO Consortium is pleased to co-sponsor the 2020 Digital Technology in Clinical Trials Conference, March 30-31 in Boston. Register now:

    Poništi
  6. 17. pro 2019.

    Great for a Sr. Project Manager w/ 's Critical Path for Disease . Apply now if working to advance tools in excites you!

    Poništi
  7. 16. pro 2019.

    The team honored Dr. and Dr. Martha Brumfield Friday announcing that the main boardrooms at headquarters will be renamed after them in honor of their lasting and significant contributions to C-Path. Congrats!

    Poništi
  8. 9. pro 2019.

    C-Path’s John-Michael Sauer was honored to be a panel member at today’s public meeting addressing drug safety and efficacy for liver diseases. More:

    Poništi
  9. 5. pro 2019.

    New summary available from C-Path, and , Advancing the Development and Implementation of Analysis Data Standards: Key Challenges and Opportunities.

    Poništi
  10. 4. pro 2019.

    Join C-Path panelists for public , Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision Making, Dec. 6. Attend online:

    Poništi
  11. 28. stu 2019.

    Grateful today and every day for our collaborators and staff who help us accelerate the path to a healthier world.

    Poništi
  12. 26. stu 2019.

    C-Path staff to discuss pathophysiology and the impact of liver dysfunction on pharmacokinetics, pharmacodynamics, Dec. 9 public meeting sponsored by . Register:

    Poništi
  13. 25. stu 2019.

    C-Path’s T1D Consortium is progressing a quantitative modeling approach to optimize trial designs in T1D: .

    Poništi
  14. 19. stu 2019.

    C-Path, in collaboration with and , is convening the 2019 this week. Learn more about our collaborative efforts to accelerate cures for IBD and peek at the agenda here: .

    Poništi
  15. 14. stu 2019.

    In honor of , C-Path is highlighting the work its Type 1 Diabetes is doing in collaboration with and the in autoantibodies as a way to prevent .

    Poništi
  16. 13. stu 2019.

    RDCA-DAP, developed by C-Path and , provides new tools and methodologies to improve design and empower the community. Access video + event presentations from the launch:

    Poništi
  17. 8. stu 2019.

    Thank you for hosting C-Path’s Polycystic Kidney Disease Outcomes Consortium. PKDOC is committed to developing tools and processes that lead to development and regulatory approval of new treatments in .

    Poništi
  18. 7. stu 2019.
    Poništi
  19. 5. stu 2019.

    Through support from the , C-Path’s Multiple Sclerosis Outcome Assessment Consortium validated four clinical measurement tools that detect changes in walking, vision, cognition and manual dexterity. Access:

    Poništi
  20. proslijedio/la je Tweet

    : last year our Biomarkers Consortium & accomplished the 1st ever qualification of a clinical safety awarded by the as a result of the FNIH Kidney Safety Project.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·